INDUCE: A Prospective 2-Year Spine Registry
NCT: NCT06971835 · ENROLLING_BY_INVITATION
Brief Summary
The primary objective of this prospective, observational registry study is to evaluate the safety and effectiveness of Natural Matrix Protein® (NMP®) when used to promote fusion in the cervical or lumbar spine. The secondary objective is to assess patient reported outcomes following the use of NMP in the treatment of the spine.
Frequently Asked Questions
What is INDUCE: A Prospective 2-Year Spine Registry?
INDUCE: A Prospective 2-Year Spine Registry is a clinical trial registered under NCT06971835. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT06971835?
The current status of NCT06971835 (INDUCE: A Prospective 2-Year Spine Registry) is: ENROLLING_BY_INVITATION.
When did INDUCE: A Prospective 2-Year Spine Registry start?
INDUCE: A Prospective 2-Year Spine Registry started on 2026-02-17.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.